OQS
TWST icon

Occudo Quantitative Strategies’s Twist Bioscience TWST Stock Holding History

Occudo Quantitative Strategies’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,407
Closed -$790K – 1387
2022
Q3 		$790K Sell
22,407
-13,651
-38% -$580K 0.06% 502
2022
Q2 		$1.26M Buy
+36,058
New +$1.28M 0.1% 302

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Occudo Quantitative Strategies's TWST Position: Q4 2022 in Review

Occudo Quantitative Strategies sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 22,407 shares — an estimated $790K sold.

Occudo Quantitative Strategies first reported a position in TWST in Q2 2022 and held it in 2 quarters. The position peaked at $1.26M in Q2 2022. 198 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

  • Occudo Quantitative Strategies reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 22,407 Twist Bioscience shares in Q4 2022, an estimated $790K.
  • Occudo Quantitative Strategies first reported a position in Twist Bioscience in Q2 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Twist Bioscience position peaked at $1.26M in Q2 2022.
  • 198 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.